Viking Therapeutics, Inc. (VKTX) Outperforms Broader Market: What You Need to Know
The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $32.07, representing a +1.39% change from its previous close.…
32,000$
-0,22%
Echtzeit-Aktienkurs Viking Therapeutics Inc.
Bid:
Ask:
Nachrichten zur Viking Therapeutics Inc. Aktie
The Best Stocks to Invest $1,000 In Right Now
Key PointsThese stocks offer exposure to three different industries and add to the diversification of your portfolio.You can bet on…
Viking Therapeutics, Inc. (VKTX) Rises Higher Than Market: Key Facts
Viking Therapeutics, Inc. (VKTX) reached $31.29 at the closing of the latest trading day, reflecting a +2.93% change compared to…
Better Growth Buy: Eli Lilly vs. Viking Therapeutics
Key PointsEli Lilly is a leader in the weight loss drug market, generating blockbuster revenue.Viking Therapeutics recently launched a phase…
Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity
Key PointsWall Streets smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all downside…
Viking Therapeutics, Inc. (VKTX) Rises Higher Than Market: Key Facts
Viking Therapeutics, Inc. (VKTX) closed at $28.19 in the latest trading session, marking a +1.7% move from the prior day.…
2 Beaten-Down Stocks With Massive Upside Potential
There are many promising corporations that investors can buy on a dip due to recent market volatility or company-specific issues…
Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?
The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of Wall…
10 Incredible Growth Stocks Poised for Long-Term Gains
Growth stocks have been on a tumultuous ride in 2025. The confluence of geopolitical turmoil, high interest rates, the artificial…
Got $200? 2 Biotech Stocks to Buy and Hold Forever
Some potential investors hesitate to get started on building an investment portfolio because they think they need thousands of dollars…
Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note
The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $26.52, representing a -5.86% change from its previous close.…
Why This Weight Loss Drug Companys Stock Surged Today
Shares in biopharmaceutical company Viking Therapeutics (NASDAQ: VKTX) were up by 6.3% at 12:30 a.m. ET today. The move likely…
3 Growth Stocks Im Loading Up On
Growth stocks are having a moment. Several small- and mid-cap stocks have suddenly jumped 40% or more in the past…
My 5 Favorite Dirt Cheap Stocks to Buy Right Now
Though indexes have rebounded, the first half of the year has been rocky for investors. The market had to digest…
2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts
If youre looking to add growth to your portfolio, biotech stocks can be a great choice. Exciting research is happening…
Viking Therapeutics, Inc. (VKTX) Dips More Than Broader Market: What You Should Know
In the most recent trading session, Viking Therapeutics, Inc. (VKTX) closed at $26.01, indicating a -1.03% shift from the previous…
Missed Out on Eli Lillys 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.
Eli Lilly (NYSE: LLY) has been one of the hottest healthcare stocks to own in recent years, thanks in large…
Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet
According to the average brokerage recommendation (ABR), one should invest in Viking Therapeutics (VKTX). It is debatable whether this highly…
Are These 2 High-Flying Growth Stocks Still Worth Buying After Recent Pullbacks?
When markets get jittery, high-growth stocks often take the biggest hits. But for investors with a stomach for volatility and…
Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note
The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $28.59, representing a -1.26% change from its previous close.…
1 Stock Down 34% This Year to Buy and Hold
Shares of Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech, are down by 34% this year. This poor performance may suggest…
Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know
The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $26.61, representing a +1.88% change from its previous close.…
Could Viking Therapeutics Become the Next Eli Lilly?
The obesity treatment market is booming, with groundbreaking drugs like Eli Lillys (NYSE: LLY) Zepbound delivering transformative patient results and…
3 Best Growth Stocks to Buy in June
Growth investors have had to work harder than usual to find winners in 2025. With the S&P 500 essentially flat…
Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Streets Bullish Views?
The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of Wall…
Viking Therapeutics: Obesity Candidates Must Prove Their Edge As Market Matures (Upgrade)
…
Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock Has More Upside?
With VKTX surging on clinical results and NVO investing to cement market share, investors face a high-stake GLP-1 showdown.…
Better Weight Loss Stock: Amgen or Viking Therapeutics?
Investors looking to cash in on the fast-growing market for weight management medicines will naturally turn to the two leaders…
Viking Therapeutics: Weight-Loss Story Remains Intact
…
Viking Therapeutics: A High Potential Biotech Play With Manageable Risks
…
Why Viking Therapeutics Stock Bumped 3% Higher Today
A major C-suite change at a potential competitor was a key factor behind the rise of Viking Therapeutics (NASDAQ: VKTX)…
Why Weight-Loss Developer Stocks Tumbled on Tuesday
Makers of weight-loss drugs, the hottest segment of the pharmaceutical market just now, werent looking so hot on the stock…
2 Monster Stocks in the Making to Buy Now and Hold for 10 Years
Investing in promising companies before their stock prices soar is an excellent recipe for earning life-changing returns. However, with hundreds…
3 Monster Stocks in the Making
Think of some of the biggest and most successful stocks on the market. Now, go back 20 or 30 years.…
Why Viking Therapeutics Stock Surged Nearly 20% Higher in April
One of the best catalysts for a stocks rise is the withdrawal of a rival. That was an important dynamic…
Why Viking Therapeutics Stock Was Victorious This Week
Viking Therapeutics (NASDAQ: VKTX), a biotech that has shot to prominence thanks to a weight-loss drug it is developing, was…
Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday
GLP-1 drug prices are falling. Thats good news for patients, but perhaps not such good news for pharmaceutical stock investors.…
Is Novo Nordisk Stock a Buy?
For years, Denmark-based Novo Nordisk (NYSE: NVO) was a fairly traditional develop-and-market pharmaceutical company that escaped notice by many investors.…
1 Beaten-Down Stock to Buy and Hold for 10 Years
Viking Therapeutics (NASDAQ: VKTX) was one of the hottest biotech stocks of 2024; its shares soared last year following excellent…
Why Viking Therapeutics Stock Popped Today
2025 is the year we learn whether Viking Therapeutics stock will be a winner.…
Think Its Too Late to Buy Novo Nordisk? Heres the Biggest Reason Why Theres Still Time.
Almost unarguably, the most significant story in our time with the pharmaceutical industry is the emergence and sharp rise of…
Did Eli Lilly Just Say Checkmate to Novo Nordisk?
Novo Nordisk (NYSE: NVO) has seen revenue soar in recent years thanks to two drugs that have helped people around…
Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know
The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $23.94, representing a +1.44% change from its previous close.…
2 Stocks Down by 25% or More This Year to Buy and Hold
Equity markets have had a rough go of it this year due to President Trumps macroeconomic policies. Though it can…
Viking Therapeutics: A Lot More Compelling After The Meltdown - Initiating Cautious Buy (Rating Upgrade)
…
Viking Therapeutics: Trading The Volatility Of The Weight Loss Drug Market
…
Viking Therapeutics VK2735 Candidate Likely Boosted By Pfizers Woes
…
Down 71%, Should You Buy the Dip on Viking Therapeutics Stock?
No one ever claimed investing in the biotech industry was a smooth ride, but for shareholders of Viking Therapeutics (NASDAQ:…
3 Magnificent Stocks That Could Double or More by 2030
When the stock market is as turbulent as it is these days, its easy to forget the times when things…
Viking Therapeutics Aktie: VK2735 als Hoffnungsträger mit modernem Wirkansatz
New York (www.aktiencheck.de) - Viking Therapeutics-Aktienanalyse von Goldman Sachs:
Richard Law, Analyst von Goldman Sachs, nimmt die Coverage der Aktie von…